Significant inhibition of human CD8+ cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen

Transplantation

Volumn 81, Issue 5, 2006, Pages 789-796

  Kawamoto, Koichi ^a   Tanemura, Masahiro ^a,b   Nishida, Toshiro ^a   Fukuzawa, Masahiro ^a   Ito, Toshinori ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cellular immunity; Fas antigen; Fas ligand; Human CTL; Xenotransplantation

Indexed keywords

CHROMIUM 51; CONCANAMYCIN A; DEATH RECEPTOR; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; CELL SELECTION; CELL STIMULATION; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENDOTHELIUM CELL; EVALUATION; EXAMINATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC STABILITY; GENETIC TRANSFECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; MAGNETISM; MEMBRANE BINDING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SWINE; T LYMPHOCYTE SUBPOPULATION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, HETEROPHILE; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT REJECTION; HUMANS; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; SEQUENCE DELETION; SWINE; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 33645065134     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000199266.07237.25     Document Type: Article

References (46)

1. Auchincloss H, Jr. Xenogeneic transplantation. A Review. Transplantation 1988; 46: 1.
2. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
3. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
4. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
5. Sandrin MS, Vaughan HA, Dabkowsky PL, McKenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
6. Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest 2000; 105: 301.
7. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-Galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089.
8. Phelps CJ, Koike C, Vaught TD, et al. Production of α1,3- Galactosyltransferase-deficient pigs. Science 2003; 299: 411.
9. Kuwaki K, Tseng YL, Dor FJMF, et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29.
10. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3- galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32.
11. Auchincloss H, Jr. Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
12. Itescu S, Kwiatkowski P, Artrip JH, et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998; 59: 275.
13. Sasaki H, Xu X, Monahakumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and independent pathways. J Immunol 1999; 163: 6301.
14. Murray AG, Khodadoust MM, Pober JS, Bothwell ALM. Porcine aortic endothelial cells activated human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 11.
15. + cytolytic T cell clones. Transplantation 1997; 64: 340.
16. Yi S, Feng X, Hawthorne W, et al. CD8+ T cells are capable of rejecting pancreatic islet xenografts. Transplantation 2000; 70: 896.
17. Zhan Y, Brady JL, Sutherland RM, Lew AM. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perform killing. J Immunol 2001; 167: 6279.
18. + T cells of discordant xenograft recipients. Transplantation 2002; 74: 1587.
19. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233.
20. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169.
21. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806.
22. Berke G. The CTL's kiss of death. Cell 1995; 81: 9.
23. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449.
24. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355.
25. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789.
26. Lau HT, Ming Y, Adriano F, Stoeckert CJ. Prevention of islet allografts rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.
27. Rodriguez-Gago M, Heredia RA, Ramirez P, et al. Human anti-porcine γα T-cell xenoreactivity is inhibited by human FasL expression on porcine endothelial cells. Transplantation 2001; 72: 503.
28. Allison J, Georgiou HM, Strasser A, Vaux DL. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 1997; 94: 3943.
29. Kang SM, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997; 3: 727.
30. Seino K, Iwabuchi K, Kayagaki N, et al. Chemotactic activity of soluble Fas ligand against phagocytes. J Immunol 1998; 161: 4484.
31. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998; 4: 31.
32. Itoh N, Nagata S. A novel protein domain required for apoptosis; mutational analysis of human Fas antigen. J Biol Chem 1993; 268: 10932.
33. Miyagawa S, Shirakura R, Iwata K, et al. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis. Transplantation 1994; 58: 834.
34. Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perform- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156: 3678.
35. Woo JT, Shinohara C, Sakai K, et al. Isolation, characterization and biological activities of Concanamycins as inhibition of lysosomal acidification. J Antibiotics 1992; 45: 1108.
36. Drose S, Bindseil KU, Bowman EJ, et al. Inhibitory effect of modified Bafilomycins and Concanamycins on P- and V-type adenosinetriphosphatases. Biochem 1993; 32: 3902.
37. + T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J Immunol 2003; 170: 2205.
38. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990; 18: 5322.
39. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med 1996; 2: 317.
40. Warrens AN, Simonn AR, Theodore PR, Sykes M. Human-porcine receptor compatibility within the immune system: relevance for xenotransplantation. Xenotransplantation 1999; 6: 75.
41. Motegi-Ishiyama Y, Nakajima Y, Hoka S, Takagaki Y. Porcine Fas-ligand gene: genomic sequence analysis and comparison with human gene. Mol Immunol 2002; 38: 581.
42. Alexander LJ, Troyer DL, Rohrer GA, et al. Physical assignments of 68 porcine cosmid and lambda clones containing polymorphic microsatellites. Mammal Genome 1996; 7: 368.
43. Reissmann UBM, Sonntag KC, Gilli UO, et al. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity. Xenotransplantation 2004; 11: 43.
44. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935.
45. Komoda H, Miyagawa S, Kubo T, et al. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004; 11: 237.
46. Rayat GR, Rajotte RV, Hering BJ, et al. In vitro and in vivo expression of Gal alpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol 2003; 177: 127.